Department of Pathology
Sasinya N Scott has not added Biography.
If you are Sasinya N Scott and would like to personalize this page please email our Author Liaison for assistance.
Genome sequencing identifies a basis for everolimus sensitivity.
Science (New York, N.Y.) Oct, 2012 | Pubmed ID: 22923433
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2013 | Pubmed ID: 23444215
Memorial Sloan-Kettering Cancer Center
Helen H Won1,
Sasinya N Scott1,
A. Rose Brannon1,
Ronak H Shah1,
Michael F Berger1,2
1Department of Pathology, Memorial Sloan-Kettering Cancer Center,
2Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
Research
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved
